Zhejiang Shouxiangu Pharm Co (603896) — Cash Flow-to-Debt Ratio
Zhejiang Shouxiangu Pharm Co (603896) has a Cash Flow-to-Debt Ratio of 0.02x as of September 2025, meaning its operating cash flow of CN¥20.94 Million could theoretically repay 0% of its total liabilities (CN¥841.89 Million) in one year. Check 603896 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Zhejiang Shouxiangu Pharm Co Cash Flow-to-Debt Ratio (2012–2025)
Historical debt coverage capacity for Zhejiang Shouxiangu Pharm Co across 14 annual periods. Also explore Zhejiang Shouxiangu Pharm Co total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Zhejiang Shouxiangu Pharm Co (2012–2025)
Year-by-year debt coverage analysis for Zhejiang Shouxiangu Pharm Co. For market capitalisation and broader financial context, see Zhejiang Shouxiangu Pharm Co (603896) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.22x | CN¥228.07 Million | CN¥1.02 Billion | ▼ -12.4% |
| 2024 | 0.25x | CN¥213.44 Million | CN¥837.17 Million | ▼ -18.8% |
| 2023 | 0.31x | CN¥315.06 Million | CN¥1.00 Billion | ▼ -12.5% |
| 2022 | 0.36x | CN¥341.28 Million | CN¥950.67 Million | ▼ -58.6% |
| 2021 | 0.87x | CN¥296.70 Million | CN¥342.41 Million | ▲ +26.2% |
| 2020 | 0.69x | CN¥256.36 Million | CN¥373.28 Million | ▼ -44.4% |
| 2019 | 1.24x | CN¥207.92 Million | CN¥168.31 Million | ▲ +48.9% |
| 2018 | 0.83x | CN¥171.51 Million | CN¥206.79 Million | ▼ -57.6% |
| 2017 | 1.96x | CN¥110.80 Million | CN¥56.60 Million | ▲ +259.0% |
| 2016 | 0.55x | CN¥95.52 Million | CN¥175.17 Million | ▲ +52.2% |
| 2015 | 0.36x | CN¥85.03 Million | CN¥237.38 Million | ▼ -37.2% |
| 2014 | 0.57x | CN¥102.90 Million | CN¥180.43 Million | ▼ -4.9% |
| 2013 | 0.60x | CN¥65.85 Million | CN¥109.85 Million | ▲ +79.3% |
| 2012 | 0.33x | CN¥45.36 Million | CN¥135.64 Million | — |